MEDICINOVA INC (MNOV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5M 5M 7.5M Q2 '12: 493.6K Q3 '12: 83.8K Q4 '12: 34K Q1 '13: 3.3K Q2 '13: 257 Q3 '13: 0 Q4 '13: 6M Q1 '14: 0 Q1 '15: 0 Q1 '21: 4M Q2 '21: 0 Q3 '21: 37.5K Q4 '21: 0 Q3 '23: 1M Q4 '23: 0 Q2 '25: 134.6K Q3 '25: 123.3K Q4 '25: 151.7K Q1 '26: 187K Q2 '26: 458.4K Q3 '12 Q2 '13 Q1 '14 Q2 '21 Q3 '23 Q3 '25 Q2 '26

Gross Profit Quarterly

0 200K 400K 600K Q2 '10: 0 Q3 '10: 0 Q2 '11: 0 Q3 '11: 0 Q4 '11: 0 Q1 '12: 191.2K Q2 '12: 493.6K Q3 '12: 83.8K Q1 '13: 3.3K Q2 '13: 257 Q3 '13: 0 Q2 '10 Q2 '11 Q4 '11 Q2 '12 Q1 '13 Q3 '13

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -3.6M Q4 '21: -2.1M Q1 '22: -3.4M Q2 '22: -4.1M Q3 '22: -3.9M Q4 '22: -3.2M Q1 '23: -3M Q2 '23: -3.3M Q3 '23: -1.1M Q4 '23: -2.5M Q1 '24: -3.1M Q2 '24: -3M Q3 '24: -3.3M Q4 '24: -3.2M Q1 '25: -3.2M Q2 '25: -3.6M Q3 '25: -3.4M Q4 '25: -3.1M Q1 '26: -2.8M Q2 '26: -2.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -3.6M Q4 '21: -2.1M Q1 '22: -3.4M Q2 '22: -4M Q3 '22: -3.7M Q4 '22: -3M Q1 '23: -2.9M Q2 '23: -2.9M Q3 '23: -723.1K Q4 '23: -2.1M Q1 '24: -2.8M Q2 '24: -2.6M Q3 '24: -2.9M Q4 '24: -2.8M Q1 '25: -2.9M Q2 '25: -3.3M Q3 '25: -3.1M Q4 '25: -2.8M Q1 '26: -2.6M Q2 '26: -2.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 Q2 '10: 0 Q3 '10: 0 Q2 '11: 0 Q3 '11: 0 Q4 '11: 0 Q1 '12: 0 Q2 '12: 0 Q3 '12: 0 Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q2 '10 Q2 '11 Q4 '11 Q2 '12 Q1 '13 Q3 '13

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -3M Q4 '21: -3.6M Q1 '22: -3.7M Q2 '22: -2.5M Q3 '22: -2.7M Q4 '22: -4M Q1 '23: -3.2M Q2 '23: -2.4M Q3 '23: -1.4M Q4 '23: -499.1K Q1 '24: -3.9M Q2 '24: -2.8M Q3 '24: -2M Q4 '24: -1.9M Q1 '25: -3.8M Q2 '25: -2.3M Q3 '25: -1.7M Q4 '25: -2M Q1 '26: -3.5M Q2 '26: -1.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '19: -3M Q2 '19: -1.7M Q3 '19: -2M Q4 '19: -2.4M Q1 '20: -2.9M Q2 '20: -2.1M Q3 '20: -3.9M Q4 '20: -2M Q3 '21: -3M Q4 '21: -3.6M Q3 '23: -1.4M Q4 '23: -499.1K Q3 '24: -2M Q4 '24: -1.9M Q1 '25: -3.8M Q2 '25: -2.3M Q3 '25: -1.7M Q4 '25: -2M Q1 '26: -3.5M Q2 '26: -1.9M Q2 '19 Q1 '20 Q4 '20 Q3 '23 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '21: 48.8M Q3 '21: 49M Q1 '22: 49M Q2 '22: 49M Q3 '22: 49M Q1 '23: 49M Q2 '23: 49M Q3 '23: 49M Q1 '24: 49M Q2 '24: 49M Q3 '24: 49M Q1 '25: 49M Q2 '25: 49M Q3 '25: 49M Q1 '26: 49.2M Q2 '26: 49.2M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.30 -0.20 -0.10 0.00 0.10 0.20 0.30 Q3 '21: -0.22 Q4 '21: -0.20 Q1 '22: -0.27 Q2 '22: -0.26 Q3 '22: -0.26 Q4 '22: -0.28 Q1 '23: -0.27 Q2 '23: -0.25 Q3 '23: -0.19 Q4 '23: -0.17 Q1 '24: -0.17 Q2 '24: -0.16 Q3 '24: -0.21 Q4 '24: -0.23 Q1 '25: -0.23 Q2 '25: -0.25 Q3 '25: -0.25 Q4 '25: -0.24 Q1 '26: -0.23 Q2 '26: -0.21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.